Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Michael Sigl-Kraetzig"'
Publikováno v:
Angewandte Nuklearmedizin. 45:134-145
Die Radiosynoviorthese (RSO) ist fester Bestandteil der Therapie bei Patienten mit Hämophilie mit rezidivierenden Gelenkeinblutungen. 70–90% der Patienten erleben eine verminderte Blutungsfrequenz, nachlassende Schmerzen und verbesserte Beweglichk
Autor:
Katharina Holstein, Michael Sigl-Kraetzig, Jörg Wendisch, Christian Pfrepper, Christine Heller, Martin Olivieri, Robert Klamroth, Johannes Oldenburg, Manuela Krause, Ivonne Wieland, Andreas Tiede, Christoph Bidlingmaier, S. Horneff, Susan Halimeh, Christoph Königs, Heinrich Richter
Publikováno v:
Hamostaseologie. 41(3)
Background Currently available coronavirus disease 2019 (COVID-19) vaccines are approved for intramuscular injection and efficacy may not be ensured when given subcutaneously. For years, subcutaneous vaccination was recommended in patients with hemop
Autor:
Christian Pfrepper, Jörg Wendisch, Christoph Königs, Manuela Krause, Martin Olivieri, Michael Sigl-Kraetzig
Publikováno v:
Haemophilia. 25:e304-e306
Autor:
Christoph Königs, Jörg Wendisch, Manuela Krause, Christian Pfrepper, Martin Olivieri, Michael Sigl-Kraetzig
Publikováno v:
Hämostaseologie.
Autor:
Robert Klamroth, P. Jesse, Michael Sigl-Kraetzig, T. Denecke, C. Wermes, Susanne Holzhauer, J. Ruthenberg, B. Spors
Publikováno v:
Science meets clinical practice.
Autor:
Niklas Deeg, Lars Fischer, Dimitiros A Tsakiris, Martina Bührlen, Michael Sigl-Kraetzig, Karin Kurnik, Kirstin Sandrock-Lang, Susan Halimeh, Martin Hund, Katharina Kraetzer, B. Brand, Sentot Santoso, Verena Wiegering, Johannes Oldenburg, Barbara Zieger, Anja Kahle, Eileen Busse
Publikováno v:
Thrombosis and Haemostasis. 113:782-791
SummaryGlanzmann thrombasthenia (GT) is an autosomal recessive bleeding disorder characterised by quantitative and/or qualitative defects of the platelet glycoprotein (GP) IIb/IIIa complex, also called integrin αIIbβ3. αIIbβ3 is well known as a p
Autor:
Michael Achenbach, Matthias Albrecht, Marcus Benz, Renate Berger, Denise Both, Matthias Brockstedt, Uwe Büsching, Birgit Delisle, Rupert Dernick, Stefan Eber, Gabriele Ellsäßer, Ulrich Fegeler, Folkert Fehr, Ricarda Flöttmann, Regina Gaissmaier, Wilhelm Geilen, Maija Gempp, Wolfgang Gempp, Ulrike Gitmans, Ralf Gitmans, Margarete Große-Rhode, Herbert Grundhewer, Wolfram Hartmann, Michael Hermanussen, Gottfried Huss, Elke Jäger-Roman, Hermann-Josef Kahl, Thomas Kauth, Christian Kebelmann-Betzing, Heidi Keller, Gabriele Kewitz, Sabine Koch, Ingeborg Krägeloh-Mann, Christoph Kupferschmidt, Martin Lang, Otto Laub, Richard Michaelis, Manfred Mickley, Stephan Heinrich Nolte, Antonio Pizzulli, Paul L. Plener, Klaus Rodens, Hans-Georg Schlack, Ronald Schmid, Markus Schmitt, Michael Sigl-Kraetzig, Wolfram Singendonk, Klaus Skrodzki, Bernhard Stier, Harald Tegtmeyer-Metzdorf, Gabriele Trost-Brinkhues, Alexandra Wagner, Christoph Weiß-Becker, Burkhard Wermter, Stephan Wienhold
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd10c2f56fa6019188b70cbc1aee22cc
https://doi.org/10.1016/b978-3-437-21281-9.01002-1
https://doi.org/10.1016/b978-3-437-21281-9.01002-1
Publikováno v:
Blood. 126:3541-3541
Background: Sonography is applied in patients with bleeding disorders. By ultrasonography the extent of synovitis is detected as a sign of the activity of an existing hemophilic arthropathy, as a sign of progression are defects of articular cartilage
Autor:
Susanna M. Müller, Carl Friedrich Classen, Wilhelm Friedrich, Walther A. Mihatsch, Klaus-Michael Debatin, Ansgar Schulz, Michael Sigl-Kraetzig, Markus Wiesneth
Publikováno v:
Blood. 99:3458-3460
Infantile osteopetrosis (OP) carries an extremely poor prognosis unless treated early by hematopoietic stem cell transplantation. We explored the use of purified blood progenitor cells from HLA-haploidentical parents in 7 patients lacking suitable ma
Autor:
G Barbi, SM Mueller, Michael Sigl-Kraetzig, Klaus-Michael Debatin, Wilhelm Friedrich, BJ Manfras, Ansgar Schulz, Markus J. Ege
Publikováno v:
Bone Marrow Transplantation. 28:993-995
A 12-year-old boy treated for SCID at 1 month of age by HLA-haploidentical BMT developed a lymphoproliferative disease of unknown etiology at the age of 9 years characterized by sustained, marked elevation of circulating CD8+ donor T cells and by dif